Skip to main content

Table 1 Overview of studies reporting QoL in patients with KOA

From: Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review

References Country Study design QoL instrument Total Sample Size Control Population KOA Patients Mean age Gender Distribution
Cuzdan, 2017 [11] Turkey Cross-Sectional SF-36 85 25 60 65.79 Knee OA: 57 female; 3 male
Control: 13 female; 12 male
Elbaz, 2017 [12] Israel Prospective observational SF-36 93 30 63 64.2 Knee OA: 41 female; 22 male
Control: 9 female; 21 male
Lee, 2017 [13] USA Cross-Sectional SF-36 120 40 80 60.3 Knee OA: 61 female; 19 male
Control: NA
Rundell, 2017 [14] USA Prospective EQ-5D 5155 4711 368 75.3 Knee OA: 272 female; 96 male
Control 3017 female; 1694 male
Wright, 2017 [15] Australia Cross-Sectional SF-36 120 40 80 64 Knee OA: 44 female; 36 male
Araujo, 2016 [16] Brazil Cross-Sectional SF-12 93   93 60 Knee OA: 69 female; 24 male
Control: 24 female; 16 male
Bokaeian, 2016 [17] Iran Randomized clinical trial WOMAC 28   28 52.9 Knee OA: 25 female; 2 male
Cho, 2016 [18] Republic of Korea Prospective cohort study SF-36 681    71.9 Knee OA: 383 female; 298 male
Kaban, 2016 [19] Turkey Cross-Sectional SF-36 63 21 42 56.86 All female
Gomes-Neto, 2016 [20] Brazil Cross-Sectional SF-36 35   35 66.57 Knee OA: 29 female; 6 male
Khatib, 2016 [21] Australia Cross-Sectional Tot. EQ (adjusted from EQ-5D-5L) 2809   2809 68 Knee OA: 1740 female; 1069 male
Kiadaliri, 2016 [22] Sweden Population based cohort study EQ-5D 1501 744 402 71.5 Group 1 (reference group having neither knee pain nor radiographic or clinically-defined knee OA) 469 female; 275 male
Group 2 (knee pain with-out OA) 119 female; 50 male
Group 3 (kne epain with OA) 256 female; 146 male
Kiadaliri, 2016 [23]a Sweden Retrospective EQ-5D First stage 7402; Second stage 1527   The number of people diagnosis with knee OA is not specified 69.4 First stage 4604 female; 2798 male
Second stage 977 female; 550 male
Oishi, 2016 [24] Japan Cross-Sectional KOOS 963   397 54.33 Total: 595 female; 368 male
Knee OA: 299 female; 98 male
Sarumathy, 2016 [25] India Prospective study SF-36 74   74 51.7 Knee OA: 55 female; 19 male
Cavalcante, 2015 [26] Brazil Cross-Sectional WHOQOL 90 40 50 67 All female
Fang, 2015 [27] Taiwan Population based
study
SF-12 901 441 460 74.04 Total: 492 female; 409 male
Knee OA: 232 female; 209 male
Ferreira, 2015 [28] Brazil Cross-Sectional SF-36 75 35 40 68.36 All female
Kawano, 2015 [29] Brazil Cross-Sectional SF-36 93   93 61.2 Knee OA: 69 females; 24 male
Kim, 2015 [30] Korea Cross-Sectional EQ-5D 2165   2165 67.73 Knee OA: 1458 female; 707 male
Lee, 2015 [31] South Korea Cross-Sectional EQ-5D 7977   7977 61.5 Knee OA: 5448 female; 4064 male
Pang, 2015 [32] China Cross-Sectional SF-36 466   466 56.56 Knee OA: 382 female; 84 male
Rakel, 2015 [33] USA Cross-Sectional SF-36 100 25 75 56 Knee OA: 46 female; 29 male
Control: 15 female; 10 male
Reid, 2015 [34] USA Randomized controlled trial SF-36 190   190 60.2 Knee OA: 132 female; 58 male
Tsonga, 2015 [35] Greece Longitudinal SF-36 68   68 73 Knee OA: 57 female; 11 male
Visser, 2015 [36] Netherlands Cross-Sectional SF-36 1262 1060 205 56 Total: 707 female; 578 male
Knee OA: 125 female; 80 male
Control: 583 female; 477 male
Alburquerque-garcía, 2015 [37] Spain Cross-Sectional SF-36 36 18 18 85 All female
Alkan, 2014 [38] Turkey Cross-Sectional SF-36 152 40 112 60 Knee OA: 85 female; 27 male
Control: 30 female 10 male
Forkel, 2014 [39] Germany Cross-Sectional KOOS 22   22 47 Knee OA: 17 female; 6 male
Jahnke, 2014 [40] Germany Cross-Sectional HAS 159   159 63.5 Knee OA: 75 female; 84 male
Marks, 2014 [41] USA Cross-Sectional AIMS 21   21 70.8 All female
Pérez-Prieto, 2014 [42] Spain Prospective cohort study SF-36 716   716 72 Knee OA: 421 female; 295 male
Reis, 2014 [43] Brazil Cross-Sectional WHOQOL 12   12 67.25 All female
Alentorn, 2013 [44] Spain Cross-Sectional SF-36 391   391 70.7 Knee OA: 303 female; 89 male
Clement, 2013 [45] UK Cross-Sectional SF-12 996   996 70.32 Knee OA: 545 female; 421 male
Vulcano, 2013 [46] USA Prospective cohort study SF-36 4732   4732 66.88 Knee OA: 2881 female; 1851 male
Williams, 2013 [47] UK Cross-Sectional EQ-5D 2456   2456 71.4 Knee OA: 1494 female; 962 male
Coleman, 2012 [48] Australia Cross-Sectional SF-36 146   146 65 Knee OA: 109 female; 37 male
Gonçalves, 2012 [49] Portugal Cross-Sectional SF-36 136   136 67.2 Knee OA: 94 female; 42 male
Lim, 2012 [50] Philippine Cross-Sectional WOMAC 90    70.14 Knee OA: 68 female; 22 male
Elbaz, 2011 [51] Israel Cross-Sectional SF-36 1487   1487 61.9 Knee OA: 950 female; 537 male
Gonçalves, 2011 [52] Portugal Cross-Sectional KOOS 377   377 67.8 Knee OA: 282 females; 95 males
Norimatsu, 2011 [53] Japan Prospective population-based cohort study Japanese Knee Osteoarthritis Measure (JKOM) 333   333 64.2 All female
Ozcakir, 2011 [54] Turkey Cross-Sectional NHP 100   100 59.5 Knee OA: 83 female; 17 male
Paker, 2011 [55] Turkey Cross-Sectional SF-36 75   75 66.1 All female
Foroughi, 2010 [56] Australia Cross-Sectional SF-36 17   17 66 All female
Jenkins, 2010 [57] USA Cross-Sectional QLI-A 75   75 69 Knee OA: 57 female; 18 male
Kim, 2010 [58] Korea Prospective cohort study WOMAC 504   504 70.2 Knee OA: 274 female; 230 male
Muraki, 2010 [59] Japan Cross-Sectional SF-8 2126   2126 68.9 Knee OA: 1359 female; 767 male
Watanabe, 2010 [60] Japan Cross-Sectional Japanese Knee Osteoarthritis Measure (JKOM) 18   18 67 All female
Yildiz, 2010 [61] Turkey Cross-Sectional NHP 140   140 59.39 Knee OA: 104 females; 36 males
Debi, 2009 [62] Israel Cross-Sectional SF-36 134    66.95 Knee OA: 85 females; 49 males
Imamura, 2008 [63] Brazil Cross-Sectional SF-36 84 22 62 71.1 All female
Control 68.95
Liikavainio, 2008 [64] Finland Cross-Sectional RAND-36 107 53 54 59 All male
Control 59.24
Wang, 2008 [65] Germany Cross-Sectional SF-36 1009   1009 48.5 Knee OA: 620 female; 389 male
Nunez, 2007 [66] Spain Cross-Sectional SF-36 100   100 71.2 Knee OA: 71 female; 29 male
Salaffi, 2005 [67] Italy Cross-Sectional SF-36 264   KneeOA 108 65.7 Knee OA: 64 female; 44 male
Knee OA + Hip OA 51 Knee OA + Hip OA: 32 female; 19 male
Chacón, 2004 [68] Venezuela Cross-Sectional AIMS 126   126 64 Knee OA: 106 female; 20 male
Lam, 2000 [69] China Cross-Sectional case–control study COOP/WONCA 760   760 57.6 Knee OA: 538 female; 222 male
de Leeuw, 1998 [70] UK Prospective trial Rosser Index Matrix 101   101 71.5 Knee OA: 62 female; 39 male
Donnell, 1998 [71] France Cross-Sectional Rosser Index Matrix 221   221 No specified Knee OA: 174 female; 47 male
Ries, 1995 [72] USA Cross-Sectional AIMS 47   47 69.2 Knee OA: 44 female; 3 male
  1. SF-36/SF-12/SF-8 (n=34); EQ-5D (n=6); KOOS (n=3); AIMS(n=3); WOMAC(n=3); Rossser Index matrix (n=2); NHP (n=2);JKOM(n=2); WHOQOL(n=2);COOP/WONCA (n=1); HAS(n=1); RAND-36(n=1)
  2. aNot possible to add this article in gender calculation